IBS-D: Understanding Diarrhoea-Predominant Irritable Bowel Syndrome

What is IBS-D?

Diarrhoea-predominant irritable bowel syndrome (IBS-D) is a subtype of irritable bowel syndrome (IBS) in which diarrhoea is the dominant feature. It is neither an inflammatory disease nor an infection — no structural damage is visible on examination. It is classified as a chronic functional disorder, meaning the bowel behaves differently without being physically damaged.

IBS-D accounts for roughly 30 to 40% of all IBS cases, and IBS itself affects around 10 to 15% of adults in Western countries. Diagnosis most commonly occurs between the ages of 30 and 40, though symptoms often begin in adolescence or early adulthood.

---

Symptoms: far more than just diarrhoea

IBS-D is not simply a matter of loose stools. The full picture can be profoundly disruptive to daily life:

• Loose or watery stools, often ≥ 3 times a day, particularly in the morning or shortly after meals
• Sudden, difficult-to-control urgency
• Abdominal pain and cramping, often partially relieved after going to the toilet
• A sensation of incomplete emptying after a bowel movement
• Bloating and flatulence
• In roughly 1 in 3 people, episodes of faecal incontinence or accidental soiling

These symptoms have a real impact on social, professional, and emotional wellbeing. Leaving the house, travelling, eating out — everyday situations can become a source of significant anxiety.

---

How is it diagnosed?

There is no specific blood test or imaging technique for IBS-D. Diagnosis is clinical, based on the Rome IV criteria:

• Recurrent abdominal pain, present on at least one day per week over the previous three months
• Associated with at least two of the following: improvement after defecation, a change in stool frequency, a change in stool consistency

Further investigations are carried out to rule out other conditions (inflammatory bowel disease, coeliac disease, bacterial infection, and so on). If all results are normal and the Rome IV criteria have been met for at least six months, a diagnosis of IBS-D can be made.

---

What happens in the gut: the biological mechanisms

Why does the bowel behave this way? Several mechanisms are involved, often interacting with one another.

Accelerated transit

In people with IBS-D, the small intestine is hyperactive: intestinal contractions — both between and after meals — are more frequent and more forceful than normal, often reaching the ileum. As a result, food moves through the digestive tract too quickly, water cannot be properly absorbed, and stools arrive loose or liquid.

Visceral hypersensitivity

The enteric nervous system — the so-called "second brain" embedded in the gut wall — becomes abnormally sensitive. Signals that would go unnoticed in a healthy person are amplified and perceived as painful. This is why even an ordinary meal can trigger intense cramping.

Other contributing factors

Research points to abnormal levels of trypsin-3 (a digestive protease) in the colon, which may contribute to low-grade inflammation and increased intestinal permeability. The gut microbiome also appears to play a role, with possible dysbiosis in some patients. Finally, emotional stress and poor sleep directly amplify both hypersensitivity and gut motility via the gut-brain axis.

---

What are the management options?

There is no curative treatment, but a range of approaches can significantly reduce symptoms:

• Dietary adjustment: this is the first line of action. Identifying and avoiding personal triggers — large meals, irritating foods, caffeine, certain fermentable carbohydrates such as FODMAPs — can make a transformative difference.
• Medication: antispasmodics (anticholinergics) help ease cramping; other agents target serotonin receptors to modulate gut transit specifically in IBS-D.
• Stress management: behavioural therapies, breathing techniques, mindfulness — the gut-brain axis is a genuine therapeutic target, not merely a placebo effect.
• Probiotics: these may be helpful where dysbiosis is suspected, but the choice of strains and duration of use are worth discussing with a healthcare professional.

---

Key takeaways

IBS-D is a chronic but benign condition — it does not damage the bowel and does not progress to cancer. That said, it should not be dismissed: its impact on quality of life is frequently underestimated. A multidisciplinary, personalised approach — combining dietary changes, stress management, and medical follow-up — remains the most effective strategy.

If you recognise yourself in these symptoms, speak to your GP. An accurate diagnosis is the first step towards regaining control.

Note: This article is intended for informational purposes only. It is not a substitute for medical advice. If you are experiencing persistent digestive symptoms, please consult a healthcare professional.